SCPC Praises Bipartisan House Passage of PBM Rebate Transparency Bills
Washington, DC –The Senior Care Pharmacy Coalition (SCPC) today praised bipartisan passage of two bills in the U.S. House of Representatives to expand data disclosure from pharmacy benefit manager (PBM) middlemen as the national long term care (LTC) pharmacy advocacy group pursues one of its key goals of enhancing transparency and accountability across the entire prescription drug supply chain.
“Rep. Buddy Carter’s congressional track record of boosting public access to PBM drug pricing data and his ongoing effort to shed light on how they manipulate the pharmaceutical market and consumers is exemplary,” stated Alan G. Rosenbloom, President and CEO of SCPC.
Carter’s bill, H.R. 1781, the Payment Commission Data Act of 2019, provides the Medicare Payment Advisory Commission (MedPAC) and Medicaid and CHIP Payment and Access Commission (MACPAC) increased access to PBM rebate and drug pricing data to help Congress and the public better understand how the pharmaceutical marketplace is operating.
Rep. Spanberger’s legislation, H.R. 2115, the Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act, requires the U.S. Department of Health and Human Services (HHS) to publicly post aggregate rebate data from Medicare and Affordable Care Act (ACA) exchange plans on a drug class level. Her bill also requires Medicare Part D plans to share information with patients related to how much they will pay for a specific drug, and what alternatives would cost.
“Increased transparency on patients’ out-of-pocket costs at different pharmacies may have the effect of increasing competition and helping seniors by reducing drug costs, better enabling them to sustain their regimen and maintain their health,” Rosenbloom observed.
Both bills, he pointed out, will advance SCPC’s objective of greater transparency, expanded consumer access, and lower drug costs while supporting a more competitive marketplace for independent LTC pharmacies.
####
The Senior Care Pharmacy Coalition (SCPC) is the only national organization exclusively representing the interests of LTC pharmacies. Its members operate in all 50 states and serve 850,000 patients daily in skilled nursing and assisted living facilities across the country. Visit seniorcarepharmacies.org to learn more.
Recent Posts
-
SCPC Calls for Immediate Congressional Action to Fix Broken LTC Pharmacy Payment Model as More Drugs Become Subject to Mandatory Medicare Price Negotiations
SCPC, the leading voice for the nation’s long-term care (LTC) pharmacy community, commends the FTC for once again shining a light on the abusive practices of the big PBMs that continue to rake in massive profits while patients, pharmacies, employers and taxpayers foot the bill for ever-increasing drug prices.
-
SCPC Praises FTC for Report Highlighting Egregious PBM Abuses; Encourages Congress and New Administration to Make PBM Reform an Immediate Priority in 2025
SCPC, the leading voice for the nation’s long-term care (LTC) pharmacy community, commends the FTC for once again shining a light on the abusive practices of the big PBMs that continue to rake in massive profits while patients, pharmacies, employers and taxpayers foot the bill for ever-increasing drug prices.
-
Seniors in Long-Term Care Could Lose Access to Essential LTC Pharmacy Services Absent Action from Congress
A new study from the Senior Care Pharmacy Coalition (SCPC), the nation’s leading voice for long-term care (LTC) pharmacies, performed by CLA (CliftonLarsonAllen LLP) and with input from ATI Advisory details the significant financial impact Medicare drug price negotiations will have on LTC pharmacies that provide essential, government required services to more than two million seniors and others in long-term care.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.